Table 1.
Clinical, anthropometric, and metabolic features of the 40 very-old subjects investigated.
| Variable | Value |
|---|---|
| Women (%) | 70.0 |
| Age (years) | 84.2 ± 4.5 |
| BMI (kg.m−2) | 26.6 ± 3.4 |
| WC (cm) | 95.6 ± 9.8 |
| Body fat (%) | 17.2 ± 4.1 |
| Glycated hemoglobin (%) | 5.9 ± 0.5 |
| Fasting glucose (mg.dl−1) | 96.3 ± 11.7 |
| Type-2 diabetes (%) | 22.5 |
| SBP (mm Hg) | 143.9 ± 18.9 |
| DBP (mm Hg) | 72.7 ± 11.2 |
| Hypertension (%) | 75.0 |
| Triglycerides (mg·dl−1) | 124.3 ± 59.8 |
| Total cholesterol (mg·dl−1) | 190.9 ± 42.7 |
| HDL-c (mg·dl−1) | 52.4 ± 13.6 |
| Metabolic syndrome (%) | 50.0 |
| C-reactive protein (mg·dl−1) | 1.4 (1.0, 2.4) |
| Agatston score | 20.5 (0.2, 907.0) |
| Lumbosacral BMD (g·cm−2) | 0.89 ± 0.15 |
| Lumbosacral T-score | −1.53 ± 1.23 |
| Femural head BMD (g·cm−2) | 0.84 ± 0.14 |
| Femural head T-score | −1.00 ± 0.93 |
| Femural neck BMD (g·cm−2) | 0.70 ± 0.12 |
| Femural neck T-score | −1.45 ± 0.99 |
| Use of BMD-related drugs (%) | 47.5 |
| Exercise practitioners (%) | 50.0 |
| Aspartate aminotransferase (U/l) | 21.0 ± 6.0 |
| Alanine aminotransferase (U/l) | 15.5 ± 5.4 |
| Alkaline phosphatase (U/l) | 71.1 ± 23.0 |
| Gamma-glutamyl transferase (U/l) | 21.9 ± 11.5 |
| Uric acid (mg/dl) | 5.23 ± 1.26 |
| Total serum protein (g.dl−1) | 7.36 ± 0.46 |
| Serum creatinine (mg.dl−1) | 0.99 ± 0.33 |
| Creatinine clearance (ml.min−1) | 47.9 ± 15.2 |
Data expressed as mean ± standard deviation, proportion or median (and interquartile range). BMI = body mass index. WC = waist circumference. SBP = systolic blood pressure. DBP = diastolic blood pressure. HDL-c = high-density lipoprotein cholesterol. BMD = bone mineral density.